secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2025-03-26T23:59:59+00:00
Accession:  0001641172-25-000681
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eterna Therapeutics renames to Ernexa Therapeutics Inc. effective March 26, 2025
--------------------------------------------------------------------------------

- Company changed its name from Eterna Therapeutics Inc. to Ernexa Therapeutics Inc.
- Filed Certificate of Amendment to Restated Certificate of Incorporation with Delaware Secretary of State.
- Adopted amended and restated bylaws solely to reflect the name change.
- Effective date of name change: March 26, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000164117225000681/0001641172-25-000681-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000164117225000681/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-000681

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer